Last reviewed · How we verify

NCT06047795

Endurance Training in Patients With Post-TB Lung Disease

Completed NA Last updated 4 September 2024
What this trial tests

NA trial testing Experimental in Tuberculosis in 36 participants. Completed in 30 June 2024.

Timeline
11 September 2023
Primary endpoint
30 June 2024
30 June 2024

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment36
Start date11 September 2023
Primary completion30 June 2024
Estimated completion30 June 2024
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 18 to 50, any sex, with Tuberculosis or Post-Tuberculous Pleural Fibrosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the effects of endurance training on functional capacity and QOL(Quality of life) in patients with post-TB (tuberculosis) lung disease. Post-tuberculosis lung disease is a major health concern nowadays. There is limited evidence in the literature regarding the rehabilitation of patients with cured tuberculosis which leads to post-TB complications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Experimental

Trials testing the same drug.

Other recruiting trials for Tuberculosis

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06047795.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing